Skip to content

Kinematic Biofeedback on Gait Quality in Stroke

Effects of Kinematic Biofeedback on Gait Quality in People With Stroke

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06504836
Enrollment
40
Registered
2024-07-17
Start date
2024-10-01
Completion date
2025-12-31
Last updated
2025-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Biofeedback, Gait symmetry, Gait variability

Brief summary

Walking disorder is the most common and concerning issue for individuals with stroke. Previous studies have often used improvements in walking speed and distance as reference indicators for the advancement of gait performance in individuals with stroke. However, for individuals with chronic stroke, considering gait symmetry and variability to enhance gait quality as the primary intervention target may be more crucial. According to a literature review, it can be inferred that the application of biofeedback to detect gait quality may be an effective approach to improve gait symmetry and variability in individuals with stroke. However, there is still insufficient research evidence on this issue. Therefore, this study aims to investigate the effects of a kinematic biofeedback device system, which detects hip joint angles, on gait quality in individuals with chronic stroke.

Interventions

Gait training include treadmill and overground walking. The biofeedback device system will provide real-time feedback on hip extension angles.

Gait training include treadmill and overground walking.

Sponsors

National Yang Ming Chiao Tung University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* First stroke * Stroke onset time ≥ 6 months * Functional Ambulation Category ≥3 * Passive range of motion of affected hip extension is at least 10 degrees * Mini-Mental State Measurement score ≥ 24 points

Exclusion criteria

* Modified Ashworth Scale of affected ankle plantar flexors ≥ 2 * Muscle strength of affected ankle plantar flexors via Manual Muscle Testing ≤ 1 * Uncorrected auditory impairment * Severe cardiovascular disease or uncontrolled hypertension * Other orthopedic diseases that may affect walking ability * Other neurological disease except stroke

Design outcomes

Primary

MeasureTime frameDescription
Gait symmetry1 dayUsing GAITRite system to measure the symmetry of spatiotemporal parameters, including step length, step width, single support time, and double support time. Calculate the gait symmetry using following formula: Gait symmetry = affected side/ unaffected side.
Gait variability1 dayUsing GAITRite system to measure the coefficient of variation (CV). The mean and standard deviation will be used to calculate the coefficient of variation (CV). CV = standard deviation / mean \* 100%

Secondary

MeasureTime frameDescription
Propulsive force1 dayUsing Force plate to measure the ground reaction force

Countries

Taiwan

Contacts

Primary ContactYea-Ru Yang, PhD
yryang@nycu.edu.tw+886228267279

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026